Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Conditions

Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 1Stomach Neoplasms 1Sarcopenia 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Esophageal Squamous Cell Carcinoma 1Efficacy, Team 1Colorectal Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 1Nivolumab 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Efficacy, Team × Immune Checkpoint Inhibitors × Clear all
NCT06693440 2024-11-18

The Immune Assessment of PD-1 Antibody Therapy in Tumor

Henan Cancer Hospital

Recruiting
3,000 enrolled

Efficacy, Team

Data powered by HemOnc (CC BY 4.0) Colophon âš¡